Announcement • May 13
Ispire Technology Inc., Annual General Meeting, Jun 23, 2026 Ispire Technology Inc., Annual General Meeting, Jun 23, 2026. Reported Earnings • May 11
Third quarter 2026 earnings released: US$0.17 loss per share (vs US$0.19 loss in 3Q 2025) Third quarter 2026 results: US$0.17 loss per share (improved from US$0.19 loss in 3Q 2025). Revenue: US$18.7m (down 29% from 3Q 2025). Net loss: US$9.52m (loss narrowed 12% from 3Q 2025). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 2.6% growth forecast for the Global Tobacco industry. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 42% per year, which means it has not declined as severely as earnings. New Risk • Mar 15
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$95.4m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$14m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Negative equity (-US$7.7m). Earnings have declined by 63% per year over the past 5 years. Minor Risk Market cap is less than US$100m (US$95.4m market cap). New Risk • Mar 08
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$14m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Negative equity (-US$7.7m). Earnings have declined by 63% per year over the past 5 years. Reported Earnings • Feb 08
Second quarter 2026 earnings released: US$0.12 loss per share (vs US$0.14 loss in 2Q 2025) Second quarter 2026 results: US$0.12 loss per share (improved from US$0.14 loss in 2Q 2025). Revenue: US$20.3m (down 52% from 2Q 2025). Net loss: US$6.60m (loss narrowed 17% from 2Q 2025). Revenue is forecast to grow 45% p.a. on average during the next 2 years, compared to a 2.6% growth forecast for the Global Tobacco industry. Announcement • Nov 27
Ispire Technology Inc. Unveils Next-Gen Cannabis Hardware Ecosystem at MJBizCon 2025 Ispire Technology Inc. announced that it will unveil its fully reengineered cannabis product ecosystem at MJBizCon 2025, the world's largest cannabis industry conference and trade show. Held December 2-5 at the Las Vegas Convention Center, the event will serve as the official launchpad for Ispire's next-generation hardware suite. At the heart of this launch is Ispire's newly structured product architecture, which is designed to offer a smarter, more intuitive way for cannabis brands to navigate hardware selection. With a clean coding system, streamlined feature sets and clearly defined use cases, the new ecosystem enables faster product discovery, confident comparisons and optimal matching with each customer's formulation and performance needs. Ispire's new suite of cannabis devices include: The E-Series (Essentials): streamlined, scalable hardware for everyday formulations; EA02-10-S - A compact, draw-activated device with a streamlined profile, voltage tuning and optimized airflow--ideal for quick customization and ease of use; EA03-10-S - A mid-sized model combining sleek aesthetics with increased tank volume and dual voltage control, built for brands that prioritize both form and function; SA03-10-S/O - A versatile postless disposable device featuring puff-sense activation, clog-proof engineering and dual-sided tank windows for optimal visibility. The self-sealing fill system enhances reliability and leakage resistance, while the compact form factor and 270mAh battery deliver consistency for brands targeting high-volume, user-friendly applications; SA04-10-S/O- Built for durability and discretion, this self-sealing, single-use model balances premium feel with a minimalist footprint. The C-Series (Custom): fully custom and ODM-engineered devices built from the ground up; For brands seeking complete differentiation, the C-Series enables fully custom, ODM-engineered hardware solutions tailored to proprietary aesthetics, heating technologies, materials, form factors, performance targets or market-specific certifications. Whether adapting an existing platform or developing a device from scratch, the C-Series provides end-to-end product development support aligned with Ispire's quality and compliance standards. Each new device reflects Ispire's core principles of efficiency, safety and design simplicity. Senior executives, including John Monds, Vice President of Sales, will be available for meetings throughout MJBizCon 2025. Attendees interested in exploring Ispire's new platform or discussing partnership opportunities can schedule time directly by emailing. New Risk • Nov 07
New major risk - Negative shareholders equity The company has negative equity. Total equity: -US$1.8m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$1.8m). Earnings have declined by 68% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (11% average weekly change). Reported Earnings • Sep 16
Full year 2025 earnings released: US$0.69 loss per share (vs US$0.27 loss in FY 2024) Full year 2025 results: US$0.69 loss per share (further deteriorated from US$0.27 loss in FY 2024). Revenue: US$127.5m (down 16% from FY 2024). Net loss: US$39.2m (loss widened 166% from FY 2024). Announcement • May 16
Ispire Technology Inc. Announces CFO Changes Ispire Technology Inc. announced the appointment of Jie "Jay" Yu as the new Chief Financial Officer of the Company, effective May 15, 2025, following the departure of Jim McCormick, the former Chief Financial Officer. Mr. Yu has served as the Company's Vice President of Finance since June 2023 and is a seasoned accounting professional with extensive experience in public accounting and audit roles. Mr. Yu held public accounting roles at Crowe Horwath (Hong Kong) CPA from 2009 to 2012 and DA HUA CPA from 2012 to 2016. Mr. Yu also served as Chief Financial Officer of MTI Environmental Group from 2016 to 2018 and Luokung Technology Corp. from 2018 to 2023. He holds a Bachelor of Commerce in finance and accounting, as well as a postgraduate degree, from the University of Auckland. Announcement • May 14
Ispire Technology Inc., Annual General Meeting, Jun 24, 2025 Ispire Technology Inc., Annual General Meeting, Jun 24, 2025. Reported Earnings • May 11
Third quarter 2025 earnings released: US$0.19 loss per share (vs US$0.11 loss in 3Q 2024) Third quarter 2025 results: US$0.19 loss per share (further deteriorated from US$0.11 loss in 3Q 2024). Revenue: US$26.2m (down 13% from 3Q 2024). Net loss: US$10.9m (loss widened 83% from 3Q 2024). Revenue is forecast to grow 33% p.a. on average during the next 2 years, compared to a 2.4% growth forecast for the Global Tobacco industry. Announcement • May 01
IKE Tech LLC, Joint Venture Comprised of Ispire Technology Inc, Touch Point Worldwide Inc., and Chemular Inc. Files Component Pre-Market Tobacco Product Application and Tobacco Product Master File with U.S. FDA for its Bluetooth Low Energy System-on-a-Chip Ispire Technology Inc. announced that IKE Tech LLC has filed a component Pre-Market Tobacco Product Application (PMTA) and Tobacco Product Master File (TPMF) with the U.S. Food and Drug Administration (FDA) for its Bluetooth Low Energy (BLE) System-on-a-Chip. This filing marks a historic first: a complete PMTA submission for a standalone, interoperable, blockchain-enabled age-verification component, designed for universal integration across all Electronic Nicotine Delivery Systems (ENDS) devices. Unlike traditional systems that verify age once at purchase, IKE's platform requires continuous, real-time verification for device access, providing an unprecedented level of security against underage vaping. IKE formally requested an expedited review of the application, citing the system's potential to enhance public health. The IKE BLE chip, powered by blockchain technology, is a secure, interoperable, point-of-use identity and age-verification system designed to prevent unauthorized use of ENDS devices. In a multi-center Human Factors Validation Study submitted with the PMTA, the technology achieved: 100% effectiveness in preventing device activation by underage users, 100% accuracy in demographic verification, User error rates below 1%, underscoring ease of use for adults, 91% user satisfaction with app simplicity and functionality. The PMTA filing includes plans to publish clinical protocols for peer review, reinforcing Ispire's commitment to transparency and scientific rigor. By setting a new standard for youth prevention and device security, this technology has the potential to serve as a key enabler for expanded regulatory pathways for flavored vaping products--critical to offering adult smokers more choices while maintaining youth protections. The submission builds on a successful pre-PMTA meeting with the FDA in Fourth Quarter 2024, during which regulators confirmed their willingness to evaluate component-based PMTAs and encouraged cross-center guidance, particularly in software and data privacy areas. New Risk • Apr 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 73% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (12% average weekly change). Price Target Changed • Feb 22
Price target increased by 16% to US$9.00 Up from US$7.75, the current price target is provided by 1 analyst. New target price is 112% above last closing price of US$4.24. Stock is down 58% over the past year. The company posted a net loss per share of US$0.27 last year. Reported Earnings • Feb 09
Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2025 results: US$0.14 loss per share (further deteriorated from US$0.074 loss in 2Q 2024). Revenue: US$41.8m (flat on 2Q 2024). Net loss: US$8.00m (loss widened 99% from 2Q 2024). Revenue exceeded analyst estimates by 8.2%. Earnings per share (EPS) missed analyst estimates by 100%. Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 2.8% growth forecast for the Global Tobacco industry. Announcement • Jan 23
Ispire Technology Inc. (NasdaqCM:ISPR) announces an Equity Buyback for $10 million worth of its shares. Ispire Technology Inc. (NasdaqCM:ISPR) announces a share repurchase program. Under the program, the company will repurchase up to $10 million worth of its common stock. The program is valid for next 24 months. Board Change • Dec 13
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Director Jiangyan Zhu is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Announcement • Nov 26
Ispire Technology Inc. Launches VLT: A New Pod System Designed to Enhance the 510-Thread Vaping Experience Ispire Technology Inc. announced the launch of VLT, a vaping pod system that redefines the 510-thread experience. VLT's proprietary reload system offers a sustainable and eco-friendly solution that empowers consumers to take control of their vaping devices, addressing key concerns about environmental impact and disposable hardware waste. Unlike disposable vapor products that contribute to electronic waste by discarding the entire device, including the battery, VLT's reusable system promotes sustainability by allowing consumers to reload their pods. This means the battery isn't thrown out with each use, reducing electronic waste and making the product more environmentally friendly. The eco-friendly design, featuring a reusable battery and multiple pod sizes, reduces electronic waste and supports Ispire's commitment to environmental responsibility. A portion of VLT's proceeds will be donated to organizations dedicated to reducing non-recyclable waste, making VLT a plastic-neutral product. VLT's reloadable pods not only offer a greener alternative but are also cost-effective when compared to traditional disposable systems. For manufacturers, VLT drives operational efficiency through the Ispire ONE™? filling machine, cutting labor costs and maintaining product integrity. VLT's airtight design preserves the natural terpenes in cannabis extracts, enhancing flavor profiles and extending shelf life, setting a new standard for vaping quality. VLT elevates the vaping experience by merging the convenience of disposables with the reliability and performance of the 510-thread system. Available in a variety of pod sizes, colors, and fully customizable options, VLT caters to the needs of both THC, CBD and alternative cannabinoid users. The advanced pod technology ensures maximum terpene preservation, with an airtight chamber that prevents evaporation and ensures every draw delivers a consistent and premium experience. Announcement • Nov 19
Ike Tech LLC and Ispire Technology Inc. Announce Positive Pre-PMTA Submission Meeting with the FDA Ispire Technology Inc. and IKE Tech LLC announced a successful in person pre-PMTA (Pre-Market Tobacco Product Application) submission meeting with FDA'sCenter for Tobacco Products (CTP) for their Age Verification technology, designed to allow adult access to electronic nicotine delivery systems (ENDS) while preventing youth access to such products at point-of-use. This critical regulatory milestone marks an important step in the journey to provide an innovative, secure universal solution aimed at preventing youth access to ENDS and expanding the market for adults who choose to use flavored PMTA-authorized products. The IKE Tech Identity and Age Verification technology unlocks opportunities for adults who choose to use flavored vapor products while introducing a pioneering approach to reducing youth access and usage. IKE Tech's age-gating technology seeks to provide and support a platform for the introduction of additional PMTA approved characterizing flavors for ENDS products; assisting adult smokers seeking a transition from combustible cigarettes to reduced-risk flavored vapor alternatives. Due to its innovative design, reliance on blockchain technology, and partnership with leading Identify and Age Verification providers, the IKE Tech system is an advanced component that could be used -- in any ENDS device -- to ensure only authorized adult users can access vaping products. FDA Alignment on Key Points: Component PMTA: IKE Tech will submit a PMTA for a component, as opposed to a finished tobacco product to be sold to consumers, and the FDA indicated it will accept such a component PMTA if all statutory requirements are met. Additionally, due to the fact this component employs novel point-of-use technology, the FDA indicated it will consider a request to grant the IKE Tech system priority review. If authorized, the component PMTA would allow ENDS manufacturers to use the IKE Tech system in their finished tobacco product PMTAs, as a plug-and-play age-gating solution, which may allow for the approval of a variety of flavored ENDS products; Creation of Tobacco Product Master File (TPMF): IKE will create and file a TPMF for the IKE component. Once authorized, the component and TPMF can, subject to agreement, be available to ENDS device manufacturers for incorporation into products. IKE Tech anticipates completing the required studies for the component PMTA for the IKE Tech system, including the Identity and Age Verification component in first quarter 2025. Announcement • Oct 03
Ispire Technology Inc. Unveils Revolutionary "I-80" Vape Filling Machine at Benzinga Cannabis Capital Conference Ispire Technology Inc. is set to revolutionize the cannabis industry with its "I-80" vapor device filling machine. Unveiling at the Benzinga Cannabis Capital Conference in Chicago on October 8 and 9, the I-80 promises to redefine production efficiency with its ability to produce 4000 fully filled and sealed vapor devices per hour. The I-80 vapor filling machine sets a new standard in production capacity and efficiency for cannabis operators: Unprecedented Speed: 4,000 filled and sealed 0.5ml vapor devices per hour; Efficiency Boost: 10x faster than traditional manual methods, 2x quicker than current automated systems; Cost-Effective: Saves $1,000 for every 10,000 units produced and Eliminates Capping: Ispire's self-sealing devices remove the need for separate capping, boosting overall workflow efficiency by 1,000% over manual methods and 100% over other automated systems. Redefining the Production Landscape: When paired with Ispire's self-sealing devices, the I-80 dramatically enhances operational efficency: Eliminates the need for separate capping; Boosts operational efficiency by up to 1,000% compared to manual methods and Delivers an estimated 100% improvement over other automated systems. The I-80's launch is poised to captivate multi-state operators (MSOs), single-state operators (SSOs), and investors. Its ability to slash costs and enhance productivity makes it an irresistible proposition for industry leaders looking to gain a competitive edge. Experience the I-80's capabilities in person at the Benzinga Cannabis Capital Conference, October 8-9, at the Marriott Magnificent Mile in Chicago, IL. Announcement • Sep 14
Ispire Technology Inc. announced delayed annual 10-K filing On 09/13/2024, Ispire Technology Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. New Risk • Aug 29
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next year. Trailing 12-month net loss: US$13m Forecast net loss in 1 year: US$6.3m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$29m free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable next year (US$6.3m net loss next year). Shareholders have been diluted in the past year (4.5% increase in shares outstanding). Reported Earnings • May 15
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: US$0.11 loss per share (further deteriorated from US$0.047 loss in 3Q 2023). Revenue: US$30.0m (up 24% from 3Q 2023). Net loss: US$5.95m (loss widened 155% from 3Q 2023). Revenue missed analyst estimates by 33%. Earnings per share (EPS) also missed analyst estimates by 83%. Revenue is forecast to grow 40% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Global Tobacco industry. Board Change • May 14
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Director Jiangyan Zhu is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Announcement • May 09
Ispire Technology Inc., Annual General Meeting, Jun 25, 2024 Ispire Technology Inc., Annual General Meeting, Jun 25, 2024, at 08:00 Pacific Standard Time. Agenda: To consider election of five director nominees named in this proxy statement, each for a term of one year expiring at 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified; to ratify the appointment by the Audit Committee of the company’s Board of Directors of Marcum LLP as the company’s registered public accounting firm for the fiscal year ending June 30, 2024; to consider approval, on an advisory basis, of the executive compensation of the company’s named executive officers as described in this proxy statement; to consider approval, on an advisory basis, of the frequency of future advisory votes on executive compensation; and to transact, in the discretion of the company’s Board of Directors, such other business as may properly come before the Meeting or any adjournment thereof. Announcement • Mar 27
Ispire Technology Inc. has completed a Follow-on Equity Offering in the amount of $12.3 million. Ispire Technology Inc. has completed a Follow-on Equity Offering in the amount of $12.3 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 2,050,000
Price\Range: $6
Discount Per Security: $0.42 Announcement • Feb 21
Ispire Technology Inc. Provides Revenue Guidance for the Year Ending June 30, 2024 Ispire Technology Inc. provided revenue guidance for the year ending June 30, 2024. Revenue for cannabis vaping products for fiscal year 2024 is projected to be in the range of $80 million to $90 million, representing growth of 100% to 125% from fiscal year 2023. Revenue for tobacco vaping products for fiscal year 2024 is projected to be in the range of $95 million to $105 million, representing growth in the range of 33% to 47% from fiscal year 2023. Announcement • Feb 15
Ispire Technology Inc. announced delayed 10-Q filing On 02/14/2024, Ispire Technology Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Announcement • Feb 01
Ispire Technology Inc. has filed a Follow-on Equity Offering in the amount of $24.999997 million. Ispire Technology Inc. has filed a Follow-on Equity Offering in the amount of $24.999997 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 2,272,727
Price\Range: $11 Reported Earnings • Nov 17
First quarter 2024 earnings released: US$0.025 loss per share (vs US$0.04 loss in 1Q 2023) First quarter 2024 results: US$0.025 loss per share (improved from US$0.04 loss in 1Q 2023). Revenue: US$42.9m (up 59% from 1Q 2023). Net loss: US$1.37m (loss narrowed 31% from 1Q 2023). Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Global Tobacco industry. Announcement • Nov 15
Ispire Technology Inc. Provides Revenue Guidance for the Fiscal Year 2024 Ispire Technology Inc. provided revenue guidance for the fiscal year 2024. The company is providing the following outlook for the cannabis and tobacco vaping products for fiscal year 2024, which ends on June 30, 2024. Revenue for cannabis vaping products for fiscal year 2024 is projected at somewhere between $80 million and $90 million, representing growth between 100% and 125% from fiscal year 2023. Revenue for tobacco vaping products for fiscal year 2024 is projected at somewhere between $100 million and $110 million, representing growth between 33% and 47% from fiscal year 2023. New Risk • Nov 15
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Announcement • Sep 20
Ispire Technology Inc. Announces Revenue Guidance for 2024 Ispire Technology Inc. announced revenue guidance for 2024. The company announced the revenue for cannabis vaping products for the fiscal year 2024 is projected at somewhere between $80 million and $90 million, representing growth between 100% and 125% from fiscal year of 2023. Revenue for tobacco vaping products for the fiscal year of 2024 is projected at somewhere between $95 million and $105 million, representing growth between 25% and 40% from the fiscal year 2023. Reported Earnings • Sep 19
Full year 2023 earnings released: US$0.12 loss per share (vs US$0.037 loss in FY 2022) Full year 2023 results: US$0.12 loss per share (further deteriorated from US$0.037 loss in FY 2022). Revenue: US$115.6m (up 31% from FY 2022). Net loss: US$6.10m (loss widened 225% from FY 2022). Board Change • Aug 01
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Director Jiangyan Zhu is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Announcement • Jul 21
Ispire Technology Inc. to Unveil its Newest Technology Ispire ONE™ at Champs Trade Show 2023 Ispire Technology Inc. announced that it will unveil its most recent technology advancement for the cannabis industry, the Ispire ONE™, at the Champs Trade Show, a premier business to business trade expo, in Las Vegas, on July 19 - 22, 2023. The show attracts a diverse range of industry professionals, including smoke and vape shops, dispensaries, glass blowers, online marketers, and cultivation product and service providers worldwide. At the Champs Show, Ispire will introduce its proprietary and transformative Ispire ONE™ technology and products. Designed to eliminate capping issues in the manufacturing/co-packing process, increase consistency and quality of the filled devices, eliminate leaking, spitting, or overheating for cartridges, disposables, and PODs, improve consumer safety, as the devices are sealed in a sterilized factory environment to eliminate risk of contamination during filling process by Ispire's customers. Announcement • Jul 10
Ispire Technology Inc. Announces Board Changes Effective as of July 1, 2023, Joel Paritz resigned as a member of the Board of Directors (the “Board”) of Ispire Technology Inc. (the “Company”) as well as from his positions as chair of the Audit Committee of the Board and as member of the Compensation Committee of the Board. Mr. Paritz’s departure was not the result of any disagreement with management or the Board on any matter relating to the Company’s operations, policies or practices.Effective as of July 5, 2023, following the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Christopher Robert Burch to replace Mr. Paritz and serve as a member of the Board, a member of the Audit Committee of the Board and as a member of the Compensation Committee of the Board. Christopher Robert Burch has worked in the finance and venture capital industries for more than 15 years. Currently, Mr. Burch is consulting for Bioglobal Inc., a biopesticides company. From September 2020 to May 2022, Mr. Burch served as Chief Financial Officer at Braun Bio-Technology (Shan Dong) Co. Ltd. in China where he was responsible for fundraising and corporate strategies. Prior to that, from January 2020 to September 2020, Mr. Burch served as Chief Financial Officer at Waton Corporation Limited where he was responsible for fundraising, financial planning, cash flow management, investor relations, banking relations, securities licensing, and strategy direction. From July 2019 to November 2019, Mr. Burch worked at Zhejiang Panshi Information Technology Co. Ltd. as a Vice President responsible for corporate strategic investment. From March 2017 to July 2019, Mr. Burch served as a Managing Director at Feiyang Group Co. Ltd. in Hong Kong and China where he was responsible for fundraising and providing advisory services to the sector. Prior to joining the Company, from October 2008 to October 2014 Mr. Burch served on the board of directors of KeenHigh Technologies Limited, listed on Taiwan’s Emerging Stock Market (TW:3651). In 2006, Mr. Burch received a Master of Business Administration with a focus on technology management from Tsinghua University. In 1993, Mr. Burch received a bachelor’s degree in business administration with concentration in decision sciences from Georgia State University. In 1991, Mr. Burch received a bachelor’s degree in business administration with concentration in finance from University of Georgia. Announcement • Jul 01
Ispire Technology Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 Ispire Technology Inc. provided revenue guidance for the fourth quarter of 2023. For the quarter, the company expects total revenue at $29 million to $31 million, representing growth of 33% to 42% from the fourth quarter of 2022. Announcement • Jun 30
Ispire Technology Inc. Raises Revenue Guidance for the Fourth Quarter 2023 Ispire Technology Inc. raised revenue guidance for the fourth quarter 2023. For the quarter, company raised its revenue projection from cannabis vaping hardware at $14 million to $15 million compared to previously projected range of $12 million to $15 million. Announcement • Jun 27
Ispire Technology Inc. announced that it has received $7.969216 million in funding Ispire Technology Inc. announced a private placement of 1,117,420 shares at an issue price of $7.1318 for proceeds of $7,969,216 on June 26, 2023. The company received net proceeds of approximately $7,500,000. Announcement • May 19
Ispire Technology Inc. Provides Revenue Guidance for Fourth Quarter 2023 Ispire Technology Inc. provided revenue guidance for fourth quarter 2023. For the period, the company expects revenue for cannabis vaping products for the fourth quarter is projected at $12 million to $15 million, representing growth of 58% to 98% from the third quarter 2023.